- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05499299
Volatility and Heterogeneity of Vaccine Sentiments Means Continuous Monitoring is Needed When Measuring Message Effectiveness
August 12, 2022 updated by: The University of Hong Kong
The Effect of Optimised Online Advertising on the Uptake of COVID-19 Vaccines in Hong Kong
The success of vaccination programs often depends on the effectiveness of the vaccine messages, particularly during emergencies such as the COVID-19 pandemic.
The current suboptimal uptake of COVID-19 vaccines across many parts of the world highlights the tremendous challenges in overcoming vaccine hesitancy and refusal even in the context of a world-devastating pandemic.
The investigators conducted a randomized controlled trial in Hong Kong to evaluate the impact of seven vaccine messages on COVID-19 vaccine uptake (with the government slogan as the control).
The participants included 127,000 individuals who googled COVID-19-related information during July-October 2021.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study aims to evaluate the effectiveness of using the Google advertising platforms on influencing the uptake of COVID-19 vaccines in Hong Kong.
When completed, the rich database compiled through this proposed study will provide increased insight into vaccine hesitancy in Hong Kong.
Insights from the optimised online advertising trial can aid in providing crucial technical and theoretical support to the relevant health authorities for any potential evidence-based policy intervention in addressing vaccine hesitancy issues or the public's concerns towards vaccines in Hong Kong.
Study Type
Interventional
Enrollment (Actual)
127000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hong Kong, Hong Kong
- The University of Hong Kong
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- General users of Google search in Hong Kong
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Government
Participants were shown with the government slogan for the COVID-19 vaccine campaign in 2021.
This was the control arm.
|
Individuals who googled COVID-19 information in Hong Kong were randomized to see one of the seven ads and, if they clicked on the ads, the corresponding vaccine message on our website
|
|
EXPERIMENTAL: Comparison
The ad emphasized that vaccine uptake in Hong Kong substantially lagged behind that in comparable populations such as Singapore and the UK.
|
Individuals who googled COVID-19 information in Hong Kong were randomized to see one of the seven ads and, if they clicked on the ads, the corresponding vaccine message on our website
|
|
EXPERIMENTAL: Exemption
The ad emphasized that vaccinated people could be exempted from some disruptive control measures such as mandatory testing
|
Individuals who googled COVID-19 information in Hong Kong were randomized to see one of the seven ads and, if they clicked on the ads, the corresponding vaccine message on our website
|
|
EXPERIMENTAL: Family
The ad prompted people to get vaccinated in order to protect their family.
|
Individuals who googled COVID-19 information in Hong Kong were randomized to see one of the seven ads and, if they clicked on the ads, the corresponding vaccine message on our website
|
|
EXPERIMENTAL: Lottery
The ad prompted people to get vaccinated in order to be eligible for the numerous COVID-19 lotteries in Hong Kong
|
Individuals who googled COVID-19 information in Hong Kong were randomized to see one of the seven ads and, if they clicked on the ads, the corresponding vaccine message on our website
|
|
EXPERIMENTAL: Mortality
The ad emphasized that COVID-19 has caused millions of deaths worldwide.
|
Individuals who googled COVID-19 information in Hong Kong were randomized to see one of the seven ads and, if they clicked on the ads, the corresponding vaccine message on our website
|
|
EXPERIMENTAL: Reopen
The ad prompted people to get vaccinated to help Hong Kong reopen sooner.
|
Individuals who googled COVID-19 information in Hong Kong were randomized to see one of the seven ads and, if they clicked on the ads, the corresponding vaccine message on our website
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of bookings following each message delivery within 6 hours
Time Frame: 6 hours
|
The number of bookings made within X = 6 hours following each message delivery
|
6 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of bookings following each message delivery within 3 hours
Time Frame: 3 hours
|
The number of bookings made within X = 3 hours following each message delivery
|
3 hours
|
|
Number of bookings following each message delivery within 12 hours
Time Frame: 12 hours
|
The number of bookings made within X = 12 hours following each message delivery
|
12 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
July 1, 2021
Primary Completion (ACTUAL)
October 31, 2021
Study Completion (ACTUAL)
April 1, 2022
Study Registration Dates
First Submitted
August 10, 2022
First Submitted That Met QC Criteria
August 10, 2022
First Posted (ACTUAL)
August 12, 2022
Study Record Updates
Last Update Posted (ACTUAL)
August 16, 2022
Last Update Submitted That Met QC Criteria
August 12, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UW21-428
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Proposals should be directed to kathysleung@connect.hku.hk; to gain access, data requestors will need to sign a data access agreement
IPD Sharing Time Frame
Beginning 9 months and ending 36 months following article publication
IPD Sharing Access Criteria
Researchers who provide a methodologically sound proposal for meta-analysis.
Proposals should be directed to Kathyleung@connect.hku.hk; to gain access, data requestors will need to sign a data access agreement.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vaccine-Preventable Diseases
-
Canadian Immunization Research NetworkGlaxoSmithKline; AstraZeneca; Dalhousie University; Canadian Center for VaccinologyRecruitingPreventable Disease, VaccineCanada
-
Assiut UniversityNot yet recruitingVaccine-Preventable Diseases
-
Scandinavian Biopharma ABGöteborg University; Sahlgrenska University Hospital; AureviaCompletedHealty Volunteers | Preventable Disease, VaccineSweden
-
Children's Hospital Medical Center, CincinnatiCompletedHealth Care Utilization | Preventable Disease, VaccineUnited States
-
McMaster UniversityUniversity of Manitoba; University of Alberta; University of SaskatchewanWithdrawn
-
University of North Carolina, Chapel HillEnvironmental Protection Agency (EPA)Completed
-
Michigan State UniversityRecruitingVaccine-Preventable Diseases | HPVUnited States
-
Gamaleya Research Institute of Epidemiology and...Moscow Healthcare DepartmentRecruitingCovid19 | Vaccine Preventable DiseaseRussian Federation
-
Children's Hospital Medical Center, CincinnatiCompletedHealth Care Utilization | Vaccine Preventable DiseaseUnited States
-
Mayo ClinicCompletedVaccine Preventable DiseaseUnited States
Clinical Trials on Google ads
-
Trustees of Dartmouth CollegeEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
Bahria UniversityRecruitingCovid-19 | Medical Student | E-learningPakistan
-
NYU Langone HealthNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
McGill University Health Centre/Research Institute...CompletedTrauma | Orthopedic DisordersCanada
-
Johns Hopkins UniversityNational Institute on Aging (NIA); University of MinnesotaCompleted
-
Queen's University, BelfastAWARE NI; Northern Ireland Public Health Research NetworkCompleted
-
Mayo ClinicCompletedObsessive Compulsive Disorder | AnxietyUnited States
-
NYU Langone HealthNational Cancer Institute (NCI); National Institutes of Health (NIH)RecruitingFood SelectionUnited States
-
NHS Greater Glasgow and ClydeUniversity of Glasgow; Chief Scientist Office of the Scottish GovernmentRecruitingAcquired Brain InjuryUnited Kingdom
-
Biruni UniversityCompletedNeurorehabilitation | Clinical Assessment | Physiotherapist | Treatment PreferencesTurkey